This Week at FDA: FDA’s major reorg takes effect, rare disease grants, and a TAP update

This Week at FDA

This Week at FDAFerdous Al-Faruque

GenericsGuidanceMDUFAMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)